Chronology

Shanghai Industrial Co., Ltd. was registered in Hong Kong, owning three well-established companies: Nanyang Brothers Tobacco Co. Ltd. (NBT), The Tien Chu (Hong Kong) Company Limited, and The Wing Fat Printing Co., Ltd.

Shanghai Industrial Co., Ltd. was authorized to establish a trading department, allowing it to engage in re-export business and limited urgent import operations.

NBT raised HKD100 million in funding to purchase a new plant and introduce a complete set of equipment that was internationally advanced at the time.

Shanghai Industrial Co., Ltd. was granted the authority to decide independently whether to set up businesses in Hong Kong or abroad. This marked the beginning of its investments in Shanghai, Hong Kong, and abroad, as its operations became increasingly diversified.

Shanghai Industrial Co., Ltd. leveraged the Hong Kong financial market to engage in financing operations.

Shanghai Industrial Co., Ltd. made its first investment in Hong Kong stocks.

Hong Kong Tien Chu bought Huaguang Building located on Hennessy Road Wanchai, HongKong, and renamed it Shanghai Industrial Investment Building where the headquarter of Shanghai Industrial Co., Ltd. was located. Additionally, Shanghai Industrial Co., Ltd. partnered with the Bank of Communications (Hong Kong) Limited to finance Shanghai Jiushi Company with US$30 million, supporting infrastructure development in Shanghai.

Shanghai Industrial Co., Ltd. initiated the application to set up a group company.

Shanghai Industrial Co., Ltd. subscribed to 4 million shares of Shanghai Pudong Development Bank (SPD Bank) for CNY40 million, accounting for 4% of the total investment.

With the approval of the national and Shanghai municipal authorities, Shanghai Industrial Co., Ltd. Limited was renamed Shanghai Industrial Investment (Holdings) Co., Ltd. The Orient Shopping Center, in which SIIC participated in the investment and construction, was completed and opened, becoming the first large-scale Sino-foreign joint venture retail enterprise in Shanghai.

The Shanghai Municipal Government approved SIIC's establishment of a publicly listed company in Hong Kong. Cai Laixing was appointed as the chairman of SIIC. The company invested in the construction of the elevated road project on the west section of West Yan'an Road in Shanghai, marking SIIC's first investment in the infrastructure sector. Moreover, SIIC invested US$10 million to establish a joint venture, Shanghai Sunve Pharmaceutical Co., Ltd., marking the company's entry into the pharmaceutical industry.

Shanghai Industrial Holdings Limited (0363.HK), hereinafter referred to as "SIHL," was officially registered in Hong Kong and successfully listed on the Hong Kong Stock Exchange, opening up a new avenue for Shanghai to access international capital markets for financing. SIIC was also granted approval to establish SIIC Shanghai (Group) Co., Ltd. (hereinafter referred to as "SIIC Shanghai"), which was designated as the operational headquarters of SIIC within China.

SIIC acquired Shanghai Industrial United Holdings Co., Ltd. (600607.SH, hereinafter referred to as "SIU"), a company listed on the Shanghai Stock Exchange. To accelerate the cultivation of highly skilled management personnel urgently needed for Shanghai's economic development in the new century, SIIC invested HKD25 million to establish the "Shanghai Industrial Senior Talent Resource Development Fund."

SIIC was officially included among the 33 Hang Seng Index (HSI) constituent stocks. The Shanghai Municipal Government approved the authorization of 84.6 square kilometers of land in the Dongtan area in Chongming for unified management by SIIC. SIIC successfully navigated the impacts of the Asian financial crisis, building a positive reputation and image abroad. SIIC Shanghai also secured a credit line of CNY1 billion from the Bank of Shanghai, which helped set up preliminary financing channels.

SIIC acquired a 50% stake in Haitong Securities, becoming its largest shareholder. SIIC also spun off its subsidiaries Hangzhou Qingchunbao and Shanghai Jahwa to establish SIIC Medical Science & Technology (Group) Ltd. (referred to as "SIIC Medical Science & Technology"), which was listed on the Hong Kong Growth Enterprise Market (GEM) under the stock code 8018.

SIIC made it into the list of the S&P Asia Pacific 100 companies, as recognized by Standard & Poor's (S&P). Also, SIIC was involved in the Waigaoqiao International Container Terminal Project (Phase I) and the development of the Pudong International Information Port in Shanghai.

SIIC Medical Science & Technology spun off Shanghai Jahwa (600315.SH), which was listed on the A-share market of the Shanghai Stock Exchange. In addition, SIIC invested US$184 million in Semiconductor Manufacturing International Corporation (SMIC), making it the largest shareholder of the company.

SIIC's significant associate company, Bright Dairy & Food Co., Ltd. (600597.SH, hereinafter referred to as "Bright Dairy & Food"), was officially listed and began trading on the Shanghai Stock Exchange.

SIIC acquired Shanghai Pudong Stainless Steel Sheet Co., Ltd. (600748.SH), which was listed on the Shanghai Stock Exchange. The latter underwent restructuring and transitioned into a real estate firm, rebranding as Shanghai Industrial Development Co., Ltd (SID). SIHL purchased a 56.63% stake in SIU from SIIC. It also privatized the Hong Kong GEM-listed company, SIIC Medical Science & Technology. Additionally, SIHL invested CNY2 billion to acquire 100% of the shares in the Shanghai section of the Huning Expressway, securing a 25-year concession. It signed a framework agreement with China Energy Conservation Investment Corporation to establish General Water of China Co., Ltd., marking SIHL's entry into the water services sector. Moreover, one of SIHL's significant investments, Lianhua Supermarket Holdings Co., Ltd. (0980.HK), was listed on the Hong Kong Stock Exchange.

SIHL's stake in China's largest chip manufacturer, SMIC, was officially listed on both the New York Stock Exchange (SMI.NY) and the Hong Kong Stock Exchange (0981.HK). Further, SIIC, along with several major groups representing China's and Shanghai's strengths, jointly established Shanghai Overseas United Investment Company Limited (SOUI).

The Baltic Pearl project broke ground in Krasnoye Selo of St. Petersburg, Russia, along the Gulf of Finland. SIHL entered into an asset exchange agreement with SIU, which then became a publicly listed pharmaceutical company. The three new drugs developed by SIHL—H101, KAILIKANG or Urinary Kallidinogenase for Injection, and TNF—received Class I new drug certificates from the National Medical Products Administration (NMPA). In addition, Nanyang Brothers Tobacco Co. Ltd. celebrated its 100th anniversary.

Hu Jintao, President of China and Putin, President of the Russian Federation jointly witnessed the signing of the Strategic Partnership Agreement on the “Baltic Sea Pearl” Project in the Great Hall of the People of China. President Hu visited the large-scale integrated community project, Baltic Pearl, in St. Petersburg, Russia. The Shanghai Municipal Bureau of Planning and Natural Resources also approved the Regulatory Plan for the Dongtan Launch Zone.

Wen Jiabao Premier of the State Council inspected MicroPort Medical Shanghai Co. Ltd., which is invested in by SIHL. SIIC Shanghai acquired the Shanghai section of the Hukun Expressway. SIHL injected CNY1.515 billion (approximately HKD1.619 billion) worth of pharmaceutical assets into SIU, which was later renamed "Shanghai Industry Pharmaceutical Investment Holding Co., Ltd.," consolidating SIHL's pharmaceutical assets within Shanghai Industry Pharmaceutical Investment Holding Co., Ltd. Besides, SIHL completed a 59% equity acquisition of Shanghai Industrial Urban Development Group Limited (SIUD). The business center of the Baltic Pearl project was successfully completed and put into operation.

The CPC Shanghai Party Committee and the People’s Government of Shanghai Municipality decided that SIIC controlled the shares and restructured SPG, adjusted 60% of the equity shares of SPG held by Shanghai Huayi (Group) Company and Shanghai Industrial Investment (Group) Co., Ltd. to SIIC Shanghai. Teng Yilong was appointed Chairman of SIIC. SIHL completed the largest-scale capital injection since being listed and invested 5,546 million Hong Kong dollars to acquire the equity shares of Shanghai-Kunming Expressway (Shanghai Section) and Shanghai Four Seasons Hotel from SIIC. The residential buildings under the “Baltic Sea Pearl” Project were for sale. SIIC became a global partner of Expo 2010 Shanghai China in the field of industrial investment by signing a contract.

SIIC successfully completed its "Five In, Five Out" asset restructuring, effectively withdrawing from non-core businesses and further bolstering its real estate and infrastructure sectors. SIIC acquired 100% of the equity in Shanghai Shenyu Highway Construction Development Co., Ltd., which was incorporated into SIHL by the end of the year. A restructuring plan for SIIC aimed at merging and achieving overall public listing was approved, with all required legal procedures completed within the year. Moreover, SIIC Property secured the property management rights for the Expo Axis during Expo 2010.

Chinese Vice President Xi Jinping inspected the Baltic Pearl project. SIIC completed all transactions related to its restructuring, and the new "Shanghai Pharma" resumed trading, thus allowing SIIC's pharmaceutical business to achieve its overall public listing. SIIC signed a strategic cooperation framework agreement with Shanghai Academy of Spaceflight Technology (SAST) to promote the development of the new energy industry, marking SIIC's foray into this sector. SIHL acquired a 63.65% stake in Shanghai Industrial Development Co., Ltd. (SID) for CNY5.13 billion, actively advancing the integration of its real estate business. It also purchased approximately 45.02% of the shares in China-Singapore Realty for 2.746 billion Hong Kong dollars, becoming its largest shareholder. Additionally, SIIC Holdings acquired a controlling stake in Singapore-listed Asia Water Technology Ltd. (hereinafter referred to as "Asia Water"). SIIC intensified its development efforts in the Chongming Dongtan area, increasing the registered capital of Shanghai Industrial Dongtan Investment and Development (Group) Co., Ltd. to CNY2.5 billion. The property management work undertaken by SIIC Property at the Expo Axis was successfully completed and received widespread acclaim.

Shanghai Pharma successfully issued 696 million H-shares in Hong Kong, raising approximately HKD15.49 billion, making it the first pharmaceutical company in the country to be listed on both the A-shares and H-shares markets. The Shanghai Municipal People's Government approved the Three-Year Action Plan for the Development of SIIC Dongtan. SIUD acquired a 59% stake in Urban Development from SIHL for HKD6.1 billion. Asia Water made a move into the waste-to-energy sector by acquiring a 50% equity in the Zhejiang Wenling Hanyang waste-to-energy project.

SIIC Shanghai acquired a 23.06% stake in Hangzhou Bay Bridge Development Co., Ltd. for CNY1.466 billion. The construction of municipal infrastructure for the "Dongtan Eco-City" officially began, marking a significant progression in the development of Dongtan. SIIC Dongtan signed a framework agreement with the Shanghai Land Reserve Center for the land reserve of the Dongtan Eco-City launch zone. Asia Water upgraded from the Catalist board to the mainboard in Singapore and rebranded itself as "SIIC Environment."

The Shanghai Municipal People's Government approved the land reserve cost plan for SIIC Dongtan, and SIIC signed a land reserve contract for the first phase of the "Elderly Community" with the Shanghai Municipal Land Reserve Center. Wang Wei took on the role of chairman of SIIC. SIIC Environment acquired a 50% stake in the Shanghai Pucheng Thermal Power Waste Incineration Project and a 100% stake in Shanghai Qingpu Second Wastewater Treatment. The Baltic Pearl project officially opened its "Pearl Plaza" shopping center. Wing Fat Printing held a celebration event for its 100th anniversary.

SIIC acquired six financial and real estate companies under Shanghai International Group for CNY6.1 billion through market-oriented transfers. SIIC Dongtan and SIUD jointly established SIIC Elderly Care Investment Co., Ltd. as a platform for SIIC's elderly care industry development. Construction officially began on the first phase of SIIC Dongtan's Elderly Community project. SIIC participated in the renovation and infrastructure development of the old town focusing on the "North Bund" comprehensive development in Hongkou District. SIUD acquired a 99% stake in ShanghaiMart for HKD4.5 billion. SIIC Finance received approval to commence operations. SIIC completed the establishment of a two-way cross-border RMB cash pool in the China (Shanghai) Pilot Free Trade Zone. Shanghai SIIC Asset Management Co., Ltd. signed an agreement to increase its capital and acquire shares in Shanghai Pudong Science and Technology Investment Co., Ltd. (PDSTI).

Chiatai Qingchunbao Pharmaceutical Co., Ltd. collaborated with relevant research institutions to complete the project on "Core Technology System for the Secondary Development and Industrialization of Traditional Chinese Medicine," which was awarded the First Prize for National Science and Technology Progress Award 2014 by the State Council. SIIC Dongtan's Ruici Garden project officially began to sell to the public, marking the Dongtan project's entry into the market. The China Securities Regulatory Commission approved SID's application for a non-public issuance of up to 413 million new shares, raising no more than CNY4.8 billion. This marked the first time SID achieved equity financing, facilitating the connection of its real estate business with energy conservation and "Internet Plus" initiatives. SID successfully acquired the land use rights for state-owned construction land of Plot HK324-01 in Tilanqiao Sub-district of Hongkou District, Shanghai, for CNY3.26 billion. SIUD sold the Qi'ao Island project in Zhuhai for CNY3.1 billion. SIIC Environment acquired a 92.15% stake in Shanghai Fudan Water Engineering and Technology Co., Ltd. for CNY1.548 billion, one of the largest mergers and acquisitions in the domestic water sector in recent years.

Shanghai Pharma's project on "Developing Artificial Musk and Its Industrialization" was awarded the First Prize for National Science and Technology Progress Award 2015 by the State Council. Additionally, its project on "Analysis of Ginkgolide and Bilobalide Components" won a gold medal at the International Exhibition of Inventions Geneva, making it the only gold medal awarded to the Chinese delegation in the pharmaceutical category at the year's exhibition. Shanghai Pharma also completed the acquisition and privatization of Australian nutritional public company Vitaco, marking a significant step forward in its healthcare & pharmaceutical business. Furthermore, a 23% stake in the Hangzhou Bay Bridge was transferred to SIHL. SIHL successfully acquired Longjiang Environmental Protection Group Co., Ltd., boosting the Group's water treatment capacity to 17 million tons per day, placing it sixth in the world. SIIC Environment successfully acquired a 60% stake in Ranhill Water Technologies (Hong Kong) Ltd., a subsidiary of Malaysia-based Ranhill Utilities Berhad, facilitating its entrance into the industrial water treatment and Southeast Asian markets..

Han Zheng, member of the Political Bureau of the CPC Central Committee and Secretary of the CPC Shanghai Municipal Committee, visited SIIC to investigate the progress of deepening SOE reform. During the visit, he outlined SIIC's new positioning for the new era: "Grounded in Hong Kong and Shanghai, aligning with national strategies, and embracing an international expansion strategy." In a significant move, Shanghai Pharma acquired 100% of the shares of Cardinal Health China for US$557 million, marking the largest transaction in the history of Chinese pharmaceutical commerce. Additionally, SIHL invested HKD1.018 billion to subscribe to 300 million shares issued by Canvest Environmental Protection Group Company Limited (01381.HK), a company publicly traded in Hong Kong.

Chinese Vice President Wang Qishan conducted a field visit to the Baltic Pearl project during his visit to Russia for the 22nd St. Petersburg International Economic Forum. Shen Xiaochu was appointed Chairman of SIIC. The Shanghai Municipal Government approved the establishment of Shanghai Healthcare Capital (SHC) initiated by SIIC. Shanghai Pharma executed a quick placement of 153 million H shares, raising HKD3.129 billion in the process. The Hong Kong headquarters of Shanghai Pharma officially began operations, marking new progress in SIIC's international development strategy. Additionally, SIIC Environment successfully listed on the main board of the Hong Kong Stock Exchange, making it the first to achieve a dual listing status in both Singapore and Hong Kong (BHK.SG/00807.HK) among the Group.
Shanghai Overseas United Investment Company Limited (SOUI) was reinstated as a directly managed enterprise of the Group, which would fully leverage the Group's platform to respond to the "Belt and Road" initiative. Shanghai Baodi SIIC Industrial and Urban Development Co., Ltd. was established in Shanghai, representing a new breakthrough in the Group's services to the city.

The Shanghai Municipal People's Government officially approved the establishment and operations of Shanghai Healthcare Capital (SHC), launched by SIIC. President Xi Jinping and Russian Prime Minister Vladimir Putin jointly witnessed the signing of a memorandum of cooperation (MoC) and shareholder agreement between Shanghai Pharma and BIOCAD, Russia's largest biopharmaceutical company. This project marks a milestone in Shanghai Pharma's R&D innovation transformation and international development, paving the way for joint ventures between China and Russia in the biopharmaceutical sector. Additionally, SIIC initiated the establishment of Shanghai Cultural Industry Development Investment Fund. The Baoshan Renewable Energy Utilization Center project, with a total investment of approximately CNY3 billion, commenced construction under the management of SIIC Environment. This project is the first integrated end-of-life waste disposal project for both dry and wet waste following Shanghai's implementation of waste sorting, aiming to achieve the highest international standards and serve as a leading global model project.

Shanghai Pharma was designated as the sole procurement base for import emergency supplies and medical resources against COVID-19 in Shanghai. SIIC took on the development project of the Baowu "Special Steel" plot from Lingang Group. SIIC aimed to transform the Baowu "Stainless Steel" and "Special Steel" plots into an innovative urban area that seamlessly integrates industry and city, features coordinated functions, and is characterized as open, multifunctional, ecological, and smart. Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. (FDZJ), an innovative pharmaceutical company with Shanghai Pharma as the largest shareholder, achieved a successful listing on the STAR Market. This marked a new achievement for both SIIC and Shanghai Pharma in their innovation efforts. According to the Fortune Global 500 list for 2020, Shanghai Pharma debuted at 473rd place. SIIC acquired a 77.58% stake in Tianjin Trust for CNY9.409 billion, accelerating its growth in the broader financial services sector and furthering its strategy of merging finance with industry. SIIC partnered with several enterprises to acquire a 67% stake in TJ Pharma, speeding up the growth of Shanghai's biopharmaceutical industry. Shanghai Healthcare Capital (SHC) and the Shanghai Cultural Industry Development Investment Fund initiated and operated by SIIC were officially launched. SHC's total size is set at CNY50 billion, with nearly CNY10 billion completed in the first phase domestically. The Shanghai Cultural Industry Development Investment Fund has a total size of CNY12 billion, with a first phase management size of CNY5.55 billion. A subsidiary of SIIC purchased a 30.22% stake in SUS Environment for CNY2.9988 billion, becoming its largest shareholder, thereby elevating SIIC's waste-to-energy business to become the second largest in the country.

SIIC celebrated its 40th anniversary. Carrie Lam, the then Chief Executive of the Hong Kong Special Administrative Region, sent a congratulatory message praising the company for its deep-rooted contributions and distinguished reputation over the past four decades. She highlighted the Group's contributions to upholding the "One Country, Two Systems" principle and promoting stability and prosperity in Hong Kong. Based on this new phase and landscape, the company formulated its "14th Five-Year Plan," setting a strategic development goal to become a globally competitive and domestically leading green and health industry investment holding group. Shanghai Pharma ranked 437th on the Fortune Global 500 list. The Shanghai Biomedical Frontier Industry Innovation Center was officially inaugurated, and Shanghai Pharma introduced Yunnan Baiyao as a strategic investor with a targeted placement of 10.9 billion yuan, aiming to establish the "Clouds in the Sky" Traditional Chinese Medicine Industry Alliance. Significant projects like the Shanghai Pharmaceuticals Biotech and Pharmaceutical Industrial Base (Zhangjiang) and the Shanghai Pharmaceuticals Global Distribution Center (Lingang) were launched to enhance the science and technology innovation center's connotation. SIIC continued to steadily operate SHC to elevate its financial capabilities. Committed to the philosophy that "lucid waters and lush mountains are invaluable assets," it continued to strategically expand its environmental industry landscape. Moreover, it was actively involved in practicing the concept that "cities are built by the people and are for the people," investing in the construction of a new landmark project—the 480-meter-tall building in Puxi. Collaborating with China Baowu Steel Group Corporation Limited (China Baowu), SIIC explored investments in the Baoshan International Art Center and planned a themed residency for classic revolutionary dramas. The first phase of the SIIC Big Data Command Center was completed and put into operation.

SIIC dedicated itself to the "Defense Campaign of Greater Shanghai" and the COVID-19 pandemic control efforts in Hong Kong. Li Qiang, the then Secretary of the CPC Shanghai Municipal Committee, visited the Group to review its work on pandemic response and the provision of medical supplies. Shanghai's Mayor Gong Zheng visited SPH SINE, which is part of SIIC, alongside a party and government delegation from Yunnan Province. Zhejiang Wufangzhai Industry Co., Ltd., in which the Group is an investor, went public on the Shanghai Stock Exchange. "SIIC Medical Cosmetology Hospital" officially opened, a collaboration with Shanghai Ninth People's Hospital. Following the directives from the CPC Shanghai Municipal Committee and government, SIIC undertook the widening and renovation of the Shanghai section of Huyu Expressway (G50). the Group successfully acquired a 40% stake in Shanghai Pharma from China Worldbest Group Co. Ltd. (CWGC) for CNY6.236 billion, thereby enhancing the influence and control of SASAC over Shanghai Pharma. Chen Jining, Secretary of the CPC Shanghai Municipal Committee, attended and launched the International Biopharma Industry Week Shanghai. Shanghai Pharma was ranked 430th in the Fortune Global 500 list. SIIC entered into a Strategic Cooperation Framework Agreement with Baoshan District to support the municipal and district efforts in land purchase and reserve for two "One Square Kilometer" projects in the Wusong Innovation City. The Shanghai Baoshan Renewable Energy Utilization Center project connected to the grid, and progress was made on the Xicen water quality purification project in Qingpu, Shanghai.

SIIC took part in the 24th IE expo China as the presidential organization of the Shanghai Association of Environmental Protection Industry and a leading exhibitor at the Shanghai Pavilion. The event provided a platform for SIIC to fully showcase its achievements in ESG development, signaling a new era in its ESG governance. Gong Zheng, Deputy Secretary of the CPC Shanghai Municipal Committee and Mayor of Shanghai, conducted a site visit to the new 480-meter-high landmark project in Puxi and highlighted the importance of actively promoting urban renewal efforts to create a captivating "meet-the-world lounge." Accompanying him was Guo Fang, a member of the CPC Shanghai Municipal Committee and Vice Mayor, who also attended the project's groundbreaking ceremony.

Chen Jining, Secretary of the CPC Shanghai Municipal Committee, along with Mayor Gong Zheng and Vice Mayor Hua Yuan, visited SIIC and its affiliates. They addressed the importance of innovative transformation at SIIC and the high-quality development of its biopharmaceutical sector in the new era. Hu Wenrong, Chairman of the Shanghai Municipal Committee of the Chinese People's Political Consultative Conference, alongside a delegation from the Xinjiang Production and Construction Corps, visited SPH SINE. As a vice presidential organization of the Shanghai Association of Environmental Protection Industry, SIIC showcased its achievements at the 25th IE expo China and the 2024 Shanghai International Carbon Neutrality Expo, illustrating how it had used technological innovation to elevate its industrial capacity while actively implementing ESG practices for green and sustainable development. The Shanghai Municipal Bureau of Talent Work and the Hong Kong Talent Engage (HKTE) signed a memorandum of understanding (MoU) on talent cooperation at SIIC's headquarters in Hong Kong. Leng Weiqing, Chairman of the Group, also met with Paul Chan Mo-po, Financial Secretary of the Government of Hong Kong Special Administrative Region (HKSAR), to exchange views on further deepening their partnership.